Welcome to LookChem.com Sign In|Join Free

CAS

  • or

33900-28-6

Post Buying Request

33900-28-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

33900-28-6 Usage

Description

BOC-TRP-OME, also known as N-(tert-Butoxycarbonyl)tryptophan methyl ester, is a synthetic compound derived from the amino acid tryptophan. It is a white to off-white powder and is commonly used in the synthesis of various pharmaceutical compounds and as a reagent in organic chemistry.

Uses

Used in Pharmaceutical Synthesis:
BOC-TRP-OME is used as a building block for the synthesis of various pharmaceutical compounds, particularly those containing the tryptophan residue. Its presence in the molecule allows for the creation of a wide range of bioactive molecules with potential therapeutic applications.
Used in Organic Chemistry:
BOC-TRP-OME is used as a reagent for the preparation of trifluoroalkyl amines, which are important intermediates in the synthesis of various organic compounds. BOC-TRP-OME's reactivity and stability make it a valuable tool in organic synthesis, facilitating the formation of complex molecular structures.
Used in Research and Development:
BOC-TRP-OME is also utilized in research and development for the study of tryptophan-containing peptides and proteins. Its availability as a synthetic compound allows researchers to investigate the structure, function, and interactions of these biomolecules in a controlled manner.

Check Digit Verification of cas no

The CAS Registry Mumber 33900-28-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,9,0 and 0 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 33900-28:
(7*3)+(6*3)+(5*9)+(4*0)+(3*0)+(2*2)+(1*8)=96
96 % 10 = 6
So 33900-28-6 is a valid CAS Registry Number.

33900-28-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H66442)  N-Boc-L-tryptophan methyl ester, 96%   

  • 33900-28-6

  • 5g

  • 368.0CNY

  • Detail
  • Alfa Aesar

  • (H66442)  N-Boc-L-tryptophan methyl ester, 96%   

  • 33900-28-6

  • 25g

  • 1382.0CNY

  • Detail
  • Alfa Aesar

  • (H66442)  N-Boc-L-tryptophan methyl ester, 96%   

  • 33900-28-6

  • 100g

  • 4420.0CNY

  • Detail

33900-28-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl (2S)-3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate

1.2 Other means of identification

Product number -
Other names N-BOC-tryptophan methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:33900-28-6 SDS

33900-28-6Relevant articles and documents

Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog

Chartier, Magali,Desgagné, Michael,Sousbie, Marc,Rumsby, Charles,Chevillard, Lucie,Théroux, Léa,Haroune, Lounès,C?té, Jér?me,Longpré, Jean-Michel,Boudreault, Pierre-Luc,Marsault, éric,Sarret, Philippe

, (2021/07/07)

The current opioid crisis highlights the urgent need to develop safe and effective pain medications. Thus, neurotensin (NT) compounds represent a promising approach, as the antinociceptive effects of NT are mediated by activation of the two G protein-coupled receptor subtypes (i.e., NTS1 and NTS2) and produce potent opioid-independent analgesia. Here, we describe the synthesis and pharmacodynamic and pharmacokinetic properties of the first constrained NTS2 macrocyclic NT(8–13) analog. The Tyr11 residue of NT(8–13) was replaced with a Trp residue to achieve NTS2 selectivity, and a rationally designed side-chain to side-chain macrocyclization reaction was applied between Lys8 and Trp11 to constrain the peptide in an active binding conformation and limit its recognition by proteolytic enzymes. The resulting macrocyclic peptide, CR-01-64, exhibited high-affinity for NTS2 (Ki 7.0 nM), with a more than 125-fold selectivity over NTS1, as well as an improved plasma stability profile (t1/2 > 24 h) compared with NT (t1/2 ~ 2 min). Following intrathecal administration, CR-01-64 exerted dose-dependent and long-lasting analgesic effects in acute (ED50 = 4.6 μg/kg) and tonic (ED50 = 7.1 μg/kg) pain models as well as strong mechanical anti-allodynic effects in the CFA-induced chronic inflammatory pain model. Of particular importance, this constrained NTS2 analog exerted potent nonopioid antinociceptive effects and potentiated opioid-induced analgesia when combined with morphine. At high doses, CR-01-64 did not cause hypothermia or ileum relaxation, although it did induce mild and short-term hypotension, all of which are physiological effects associated with NTS1 activation. Overall, these results demonstrate the strong therapeutic potential of NTS2-selective analogs for the management of pain.

Asymmetric and Geometry-Selective α-Alkenylation of α-Amino Acids

Abas, Hossay,Mas-Roselló, Josep,Amer, Mostafa Mahmoud,Durand, Derek J.,Groleau, Robin R.,Fey, Natalie,Clayden, Jonathan

supporting information, p. 2418 - 2422 (2019/02/09)

Both E- and Z-N′-alkenyl urea derivatives of imidazolidinones may be formed selectively from enantiopure α-amino acids. Generation of their enolate derivatives in the presence of K+ and [18]crown-6 induces intramolecular migration of the alkeny

Synthesis, biological evaluation, and molecular modeling studies of chiral chloroquine analogues as antimalarial agents

Kondaparla, Srinivasarao,Debnath, Utsab,Dola, Vasantha Rao,Sinha, Manish,Katti, Seturam B.,Soni, Awakash,Srivastava, Kumkum,Puri, Sunil K.

, (2019/01/05)

In a focused exploration, we designed, synthesized, and biologically evaluated chiral conjugated new chloroquine (CQ) analogues with substituted piperazines as antimalarial agents. In vitro as well as in vivo studies revealed that compound 7c showed potent activity (in vitro 50% inhibitory concentration, 56.98 nM for strain 3D7 and 97.76 nM for strain K1; selectivity index in vivo [up to at a dose of 12.5 mg/kg of body weight], 3,510) as a new lead antimalarial agent. Other compounds (compounds 6b, 6d, 7d, 7h, 8c, 8d, 9a, and 9c) also showed moderate activity against a CQ-sensitive strain (3D7) and superior activity against a CQ-resistant strain (K1) of Plasmodium falciparum. Furthermore, we carried out docking and three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of all in-house data sets (168 molecules) of chiral CQ analogues to explain the structure-activity relationships (SAR). Our new findings specify the significance of the H-bond interaction with the side chain of heme for biological activity. In addition, the 3D-QSAR study against the 3D7 strain indicated the favorable and unfavorable sites of CQ analogues for incorporating steric, hydrophobic, and electropositive groups to improve the antimalarial activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 33900-28-6